← SynDRA
MAXACALCITOL
SynDRA canonical compound SYN0004343 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | VDR |
|---|
| Mechanism of action | vitamin D receptor agonist |
|---|
| Indication | hyperparathyroidism |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
- vitamin D receptor agonist
Drug classes
- Anticarcinogenic Agents
- Antineoplastic Agents
- Dermatologic Agents
- Protective Agents
Cross-references
Synonyms
- 22-oxacalcitriol
- oxarol
- 1alpha,25-dihydroxy-22-oxavitamin d3
- Oxarol
- OCT
- SCH-209579
- SCH209579
- Prezios
- Prezios (TN)
- 22-Oxacalcitriol
- Sch-209579
- 1alpha,25-Dihydroxy-22-oxavitamin D3
- maxacalcitriol
- N2UJM5NBF6
- 22-oxa-calcitriol
- Maxacalcitol [USAN]
- 22-Oxa-1,25-dihydroxyvitamin D3
- (5Z,7E)-(1S,3R)-22-oxa-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
- 1alpha,25-dihydroxy-22-oxavitamin D3 / 1alpha,25-dihydroxy-22-oxacholecalciferol
- (1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1S,3aS,7aS)-octahydro-1-[(1S)-1-(3-hydroxy-3-methylbutoxy)ethyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol
- (1s,3r,5z,7e,14beta,17alpha,20s)-20-(3-Hydroxy-3-Methylbutoxy)-9,10-Secopregna-5,7,10-Triene-1,3-Diol
- UNII-N2UJM5NBF6
- Maxacalcitol [USAN:INN]
- MC-1275
- oxacalcitriol
- Maxacalcitrol
- 22-Oxacalcitrol
- NCGC00183596-01
- 22-Oxa-1,25(OH)2D3
- Oxarol (TN)
- MAXACALCITOL [MI]
- MAXACALCITOL [INN]
- MAXACALCITOL [JAN]
- SCHEMBL2745
- MAXACALCITOL [MART.]
- MAXACALCITOL [WHO-DD]
- CHEMBL333950
- GTPL2784
Look up MAXACALCITOL in the interactive SynDRA portal →